Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

ClinicalTrials.gov ID: NCT06339008

Public ClinicalTrials.gov record NCT06339008. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.

Study identification

NCT ID
NCT06339008
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
450 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2024 (Actual)
Primary completion
Sep 2026 (Estimated)
Completion
Oct 2028 (Estimated)
Last update posted
Sep 24, 2026

2024 – 2028

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Allergy and Asthma Specialists Medical Group Huntington Beach California 92648 —
310 Clinical Research Inglewood California 90301 —
Allergy & Asthma Associates of Southern California dba. Southern California Research Laguna Niguel California 92677 —
Allergy and Asthma San Diego California 92123 —
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907-6231 —
Allergy and Asthma Diagnostic Center Tallahassee Florida 32308 —
University of South Florida Tampa Florida 33613 —
Northwestern University Chicago Illinois 60611 —
Asthma Allergy Center of Chicago River Forest Illinois 60305 —
Bluegrass Allergy Research Lexington Kentucky 40509 —
Respiratory Medicine Research Institute of Michigan, PLC Ypsilanti Michigan 48197 —
Clinical Research Institute Minneapolis Minnesota 55402 —
University of Missouri Hospital Columbia Missouri 65212 —
Allergy and Asthma Consultants St Louis Missouri 63141 —
Asthma and Allergy Center Bellevue Nebraska 68123 —
Circuit Clinical/Hudson-Essex Allergy Belleville New Jersey 07109 —
Circuit Clinical/Mercer Allergy and Pulmonary Associates Hamilton New Jersey 08619 —
Dr. Patrick Perin Teaneck New Jersey 07666 —
Smith Allergy and Asthma Horseheads New York 14845 —
Allergy Partners Asheville North Carolina 28803 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45236 —
Northwest Research Center Portland Oregon 97202 —
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
AARA Research Center Dallas Texas 75231 —
Kerrville Allergy and Asthma Associates Kerrville Texas 78028 —
Allergy, Asthma & Sinus Center Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06339008, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06339008 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →